• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Iqvia Holdings Inc (NY: IQV )

    215.66 +2.79 (+1.31%)
    Streaming Delayed Price Updated: 10:54 AM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Iqvia Holdings Inc

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies
    Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging. 
    Via Investor's Business Daily
    Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
    Biosimilars are bringing down prescription drug costs without sacrificing quality. 
    Via The Motley Fool
    IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022
    From IQVIA Holdings Inc.
    Via Business Wire
    7 Analysts Have This to Say About IQVIA Hldgs
    Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter: 
    Via Benzinga
    Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso
    From IQVIA
    Via Business Wire
    Expert Ratings for IQVIA Hldgs
    Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter: 
    Via Benzinga
    6 Analysts Have This to Say About IQVIA Hldgs
    Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter: 
    Via Benzinga
    Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67%
    HC Wainwright & Co. cut KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $48 to $16. KalVista Pharmaceuticals shares fell 1.8% to $5.06 in pre-market trading. 
    Via Benzinga
    IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022
    From IQVIA Holdings Inc.
    Via Business Wire
    IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation
    From IQVIA
    Via Business Wire
    What 5 Analyst Ratings Have To Say About IQVIA Hldgs
    Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings: 
    Via Benzinga
    5 Analysts Have This to Say About IQVIA Hldgs
    Within the last quarter, IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings: 
    Via Benzinga
    IQVIA's Q2 Earnings Surpass Expectations; Forex Hits FY22 Top-Line Forecast
    Via Benzinga
    Recap: Iqvia Holdings Q2 Earnings
      IQVIA Hldgs (NYSE:IQV) reported its Q2 earnings results on Thursday, July 21, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    New IQVIA Study Demonstrates Cost and Time Savings of Decentralized Trials
    From IQVIA
    Via Business Wire
    IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2022
    From IQVIA
    Via Business Wire
    IQVIA CFO Ron Bruehlman to Speak at Morgan Stanley Annual Global Healthcare Conference on September 13, 2022
    From IQVIA Holdings Inc.
    Via Business Wire
    IQVIA Wins Snowflake’s “Marketplace Healthcare and Life Sciences Partner of the Year” Award
    From IQVIA
    Via Business Wire
    What 5 Analyst Ratings Have To Say About IQVIA Hldgs
    Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter: 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
    Upgrades 
    Via Benzinga
    Peering Into IQVIA's Recent Short Interest
    IQVIA Hldgs (NYSE:IQV) short percent of float has fallen 20.35% since its last report. The company recently reported that it has 1.67 million shares sold short, which... 
    Via Benzinga
    7 Growth Stocks to Buy on the Dip
    These are the best growth stocks to buy on the dip. A, CDNS, GXTG, IVSG, IQV, PAYX, and SNPS are poised to deliver impressive returns. 
    Via InvestorPlace
    IQVIA Reports Second-Quarter 2022 Results
    From IQVIA Holdings Inc.
    Via Business Wire
    Earnings Preview: IQVIA Holdings
    IQVIA Holdings (NYSE:IQV) is set to give its latest quarterly earnings report on Thursday, 2022-07-21. Here's what investors need to know before the announcement. Analysts estimate that IQVIA Holdings... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
      
    Via Benzinga
    Earnings Scheduled For July 21, 2022
    Companies Reporting Before The Bell • SAP (NYSE:SAP) is projected to report quarterly earnings at $1.15 per share on revenue of $7.56 billion. 
    Via Benzinga
    How To Attend IQVIA Hldgs Q2 2022 Earnings Conference Call
    IQVIA Hldgs (NYSE:IQV) will host a conference call at 09:00 AM ET on July 21, 2022, to discuss Q2 2022 earnings results. How to Attend IQVIA Hldgs (IQV) Conference Call Follow this link to access the... 
    Via Benzinga
    IQVIA to Announce Second-Quarter 2022 Results on July 21, 2022
    From IQVIA Holdings Inc.
    Via Business Wire
    IQVIA Recognized as a Leader in Life Science Sales and Marketing IT Outsourcing Services
    From IQVIA
    Via Business Wire
    3 Biotech Stocks to Sell Now
    These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead. 
    Via InvestorPlace
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.